Doukas J, Blease K, Craig D, Ma C, Chandler LA, Sosnowski BA, Pierce GF: Delivery of FGF genes to wound repair cells enhances arteriogenesis and myogenesis in skeletal muscle
Driven by the new drug approvals (for different applications), and extensive R&D efforts of the companies (to enhance delivery mechanisms of GLP-1 drugs), the market is anticipated to witness steady growth in the coming decade
While technically not approved by the FDA for human use, consumers can purchase BPC-157 through a labeling loophole, called the research peptide loophole, on e-commerce sites or through compounding pharmacies that make rarer drugs with raw ingredients
Medical disclaimer: This page is educational and does not replace a consultation with a qualified doctor
The trial involved 1879 patients with inadequate glycemic control on metformin monotherapy, who were randomly assigned to receive tirzepatide at doses of 5 mg, 10 mg, or 15 mg, or semaglutide at a dose of 1 mg.After 40 weeks of treatment, all doses of tirzepatide were found to be noninferior and superior to semaglutide in terms of reducing glycated hemoglobin (HbA1c) levels
doi: Mattingly, T.J
